Literature DB >> 18457191

Trends in breast cancer screening and diagnosis.

Alice Rim1, Melanie Chellman-Jeffers.   

Abstract

Screening mammography is the single most effective method of early breast cancer detection and is recommended on an annual basis beginning at age 40 for women at average risk of breast cancer. In addition to traditional film-screen mammograms, digital mammograms now offer digital enhancement to aid interpretation, which is especially helpful in women with dense breast tissue. Useful emerging adjuncts to mammography include ultrasonography, which is particularly helpful for further assessment of known areas of interest, and magnetic resonance imaging, which shows promise for use in high-risk populations. Image-guided biopsy--directed by ultrasonograpy or stereotactic mammography views--plays a critical role in histologic confirmation of suspected breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18457191     DOI: 10.3949/ccjm.75.suppl_1.s2

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  9 in total

1.  A comparison of two educational methods on immigrant Latinas breast cancer knowledge and screening behaviors.

Authors:  José Luis Calderón; Mohsen Bazargan; Nisaratana Sangasubana; Ron D Hays; Patrick Hardigan; Richard S Baker
Journal:  J Health Care Poor Underserved       Date:  2010-08

2.  Diagnostic power of diffuse reflectance spectroscopy for targeted detection of breast lesions with microcalcifications.

Authors:  Jaqueline S Soares; Ishan Barman; Narahara Chari Dingari; Zoya Volynskaya; Wendy Liu; Nina Klein; Donna Plecha; Ramachandra R Dasari; Maryann Fitzmaurice
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

3.  Development and comparative assessment of Raman spectroscopic classification algorithms for lesion discrimination in stereotactic breast biopsies with microcalcifications.

Authors:  Narahara Chari Dingari; Ishan Barman; Anushree Saha; Sasha McGee; Luis H Galindo; Wendy Liu; Donna Plecha; Nina Klein; Ramachandra Rao Dasari; Maryann Fitzmaurice
Journal:  J Biophotonics       Date:  2012-07-20       Impact factor: 3.207

4.  Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.

Authors:  T A Heusner; S Hahn; C Jonkmanns; S Kuemmel; F Otterbach; M E Hamami; A R Stahl; A Bockisch; M Forsting; G Antoch
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

Review 5.  Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.

Authors:  Keneuoe Cecilia Nthontho; Andrew Khulekani Ndlovu; Kirthana Sharma; Ishmael Kasvosve; Daniel Louis Hertz; Giacomo Maria Paganotti
Journal:  Pharmgenomics Pers Med       Date:  2022-06-21

6.  Breast cancer in the personal genomics era.

Authors:  Rachel E Ellsworth; David J Decewicz; Craig D Shriver; Darrell L Ellsworth
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

7.  Application of Raman spectroscopy to identify microcalcifications and underlying breast lesions at stereotactic core needle biopsy.

Authors:  Ishan Barman; Narahara Chari Dingari; Anushree Saha; Sasha McGee; Luis H Galindo; Wendy Liu; Donna Plecha; Nina Klein; Ramachandra Rao Dasari; Maryann Fitzmaurice
Journal:  Cancer Res       Date:  2013-06-01       Impact factor: 12.701

8.  Raman spectroscopy: a real-time tool for identifying microcalcifications during stereotactic breast core needle biopsies.

Authors:  A Saha; I Barman; N C Dingari; S McGee; Z Volynskaya; L H Galindo; W Liu; D Plecha; N Klein; R R Dasari; M Fitzmaurice
Journal:  Biomed Opt Express       Date:  2011-09-14       Impact factor: 3.732

9.  The correlation between HER-2 expression and the CEUS and ARFI characteristics of breast cancer.

Authors:  Xiao-Yan Wang; Qiao Hu; Meng-Yuan Fang; Yan He; Hai-Ming Wei; Xue-Xue Chen; Bing Zhang
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.